Medico Remedies Limited (MEDICO.BO)

36.90 +0.06 (+0.16%) At close: 03:26PM IST

Medico Remedies Limited

1105/1106, Hubtown Solaris
11th Floor Opp. Telli Galli N S Phadke Marg, Andheri East
Mumbai 400069
India
91 22 2682 1054
https://www.medicoremedies.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Haresh Kapurlal Mehta	Chairman, CFO & Head of Legal	5.89M	N/A	1955
Mr. Harshit Haresh Mehta	MD, Marketing & Export Head and Director	4.91M	N/A	1985
Mr. Dinesh Navnitlal Modi	Company Secretary & Compliance Officer	N/A	N/A	N/A
Mr. Rishit Hareshbhai Mehta	Production of Technical & Quality Control Head and Whole-Time Director	4.91M	N/A	1988

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Medico Remedies Limited manufactures and sells pharmaceutical formulations in India. The company offers antibiotics and anti-infectives; beta-lactams- penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It primarily exports its products. Medico Remedies Limited was incorporated in 1994 and is based in Mumbai, India.

Corporate governance

Medico Remedies Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.